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Throughout the duration of any influenza season, 
influenza strains have the ability to evolve through 
mutation causing alterations in virulence. These 
changes may result in severe illness or death among 
susceptible populations; therefore, it is important to 
closely monitor influenza-associated hospitalizations 
and deaths. The University of Nevada, Las Vegas in 
collaboration with the Southern Nevada Health 
District analyzed data from the hospitalized influenza 
morbidity and mortality surveillance project for Clark 
County for the 2010-2011 influenza season. Among 
the study population (N= 158): the influenza strain 
type was found to be significantly associated with 
deaths (n= 25), vaccination status was not found to be 
significantly associated with death among 
hospitalized patients, and transformed data showed 
no statistically significant difference in the mean 
length of hospital stay based on the influenza strain 
type. These results will help inform public health 
agencies of the impact of influenza-associated 
hospitalizations and deaths, and inform the design of 
future surveillance systems. 
 







Disease surveillance systems are an integral part of 
any public health agency, and because of the 
unpredictable nature of the virus, influenza 
surveillance monitoring systems are particularly 
essential. The influenza virus circulates in a fairly 
predictable manner each year, typically from late fall 
to early spring; however, throughout the duration of 
any influenza season, influenza strains have the 
ability to evolve through antigenic mutations, viral 
reassortment, development of anti-viral resistance, 
and alterations in virulence (Bautista et al., 2010). 
Changes in the influenza strain may result in more 
severe illness or death. Because of this, it is 
especially important to closely monitor hospitalized 
influenza patients, as they may be more likely to be 
infected with the most virulent strains of influenza. 
Influenza surveillance systems provide a picture of 
influenza as it spreads throughout a community and, 
most importantly, they are able to serve as warning 
systems for public health officials. The objective of 
this study was to describe the epidemiology of 
severe-influenza associated hospitalizations and 
deaths for the 2010-2011 influenza season in Clark 
County, Nevada. 
 
National and state level surveillance programs are 
useful in determining the health and economic burden 
associated with influenza circulation and helping to 
prepare for future pandemics (Thompson, Comanor, 
& Shay, 2006). Surveillance systems are especially 
critical in helping to determine estimates for vaccine 
production, to anticipate antiviral medication use and 
diagnostic testing needs, and to guide vaccination 
programs in prioritizing immunization to those at the 
greatest risk for morbidity and mortality (Thompson 
et al., 2006). Surveillance measures help to assess the 
burden of influenza on the health care system, which 
tends to fluctuate seasonally, and depends upon 
which influenza strain is predominantly circulating. 
Decades of preceding trends of influenza-associated 
hospitalizations and deaths have shown a pattern of 
increased morbidity and mortality during seasons in 
which influenza A (H3N2) viruses are the 
predominantly circulating strains (Thompson et al., 
2010). Knowing this can help public health officials, 
hospitals, and community agencies prepare for 
increases in morbidity and mortality based solely on 
the predicted circulating influenza strain. 
 
Since the 2009 H1N1 pandemic, and with these 
surveillance functions in mind, the Southern Nevada 
Health District (SNHD), Office of Epidemiology 
(OOE) has conducted a severe hospitalized influenza 
morbidity and mortality surveillance program to 
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describe the epidemiology of influenza in Clark 
County, Nevada, which includes the city of Las 
Vegas and the 38 million tourists that visit annually 
(Las Vegas Convention and Visitors Authority 
[LVCVA], 2011). The SNHD severe influenza-
associated hospitalizations and deaths surveillance 
project most closely resembles the viral, morbidity, 
and mortality surveillance components of the Centers 
for Disease Control and Prevention (CDC) national 
influenza surveillance program (CDC, 2010). In this 
study, a secondary analysis was conducted of these 
surveillance data to examine severe influenza-
associated hospitalizations and deaths, and to address 
the following research questions. Among severe 
influenza-associated hospitalizations: 1) Will the 
strain of influenza be associated with death? 2) Will 
vaccination status be associated with death? and 3) 
Will there be a difference in the length of hospital 




Study Population and Inclusion Criteria 
The study population consists of all residents of 
Clark County, Nevada who were hospitalized for ≥ 
24 hours or expired between October 1, 2010 and 
May 31, 2011, and met both the clinical case 
definition and the laboratory criteria for diagnosis 
described below. 
 
Clinical case definition and laboratory criteria for 
diagnosis: 
1. Clinical case definition: Abrupt onset of at 
least two of the following specific 
symptoms: body aches, dry cough, fever, 
headache, rhinitis, severe fatigue, and/or 
sore throat. Other symptoms uncommon in 
adults, but that might occur in children were 
also included, such as: diarrhea, nausea, 
otitis media, and vomiting; AND 
2. Laboratory criteria for diagnosis: 
Including one of the following: 
a.   Isolation of the virus by culture or 
detection of virus by real time reverse 
transcription polymerase chain reaction 
(rRT-PCR) from nasopharyngeal or 
throat swabs, nasal wash or nasal 
aspirate(s);  
b.   Positive testing from a Food and Drug 
Administration (FDA) approved rapid 
diagnostic test. The rapid test is only 
acceptable as a screening method within 
the current influenza season if it has been 
confirmed by rRT-PCR or culture; 
however, it will be accepted as evidence 
of infection if the patient is hospitalized 
or has expired. 
 
The diagnostic testing methods differ based on the 
identification method employed, the type of sample 
from which evidence of influenza infection is 
extracted, and the time required to process the results. 
Rapid diagnostic testing methods detect antigens 
specific to the influenza virus type (A or B) from any 
of the following specimens (dependent upon the rapid 
test utilized): nasopharyngeal swab/aspirate, nasal 
wash/aspirate, lower nasal swab, throat swab, and/or 
bronchioalveolar lavage (CDC, 2011b). The viral 
subtype for influenza A viruses is unable to be 
identified by rapid diagnostic testing. However, the 
advantage to using rapid diagnostic testing is that 
results are processed in 10 to 15 minutes (CDC, 
2011b). There are multiple FDA approved rapid 
diagnostic tests available; however, none are as 
sensitive at detecting and/or isolating the virus as 
viral culture or rRT-PCR. 
 
Viral culture is considered to be the “gold standard” 
for influenza virus testing, but can take from 2 to 14 
days to isolate the virus from respiratory epithelial 
cells (Ruest, Michaud, Deslandes, & Frost, 2003; 
CDC, 2011b). To optimize effectiveness, initiation of 
antiviral medication is recommended within 48 hours 
of the onset of flu-like symptoms (CDC, 2011c); 
therefore, the time period required for viral culture is 
one disadvantage to its use. The rRT-PCR is another 
diagnostic testing method more sensitive than the 
rapid antigen test. The rRT-PCR requires 
approximately 2-4 hours for the results to be 
processed, which is considerably less than the viral 
culture method. Both the viral culture and rRT-PCR 
methods require specimen samples from any of the 
following: nasopharyngeal swab/aspirate, nasal 
swab/aspirate/wash, throat swab, bronchioalveolar 




Subjects excluded from the surveillance project were 
those not admitted for greater than 24 hours, did not 
test positive for influenza by any of the diagnostic 
testing methods listed, or whose primary residence 
was located outside the SNHD jurisdiction (i.e., 
Clark County). Although cases among tourists are 
reported by their home state for statistical purposes, 
the SNHD is responsible for providing public health 
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SNHD Data Collection Process 
As part of routine public health practice, the SNHD 
conducts seasonal influenza surveillance through 
passive and active methods. Laboratory-confirmed 
influenza is a reportable condition in Nevada; health 
care providers (HCPs) and clinical laboratories must 
report all cases to the designated health authority. 
 
Passive surveillance also occurs in the review of the 
cause of death (COD) listed on all death certificates 
received by the SNHD. Any deaths attributed to 
influenza are noted and actively investigated if 
further information is required to assess the clinical 
circumstances surrounding the death. Cases with 
commonly listed complications of influenza illness as 
the COD or as contributing factors were further 
investigated to elicit influenza-related infection or 
involvement. 
 
The SNHD Disease Investigation and Intervention 
Specialist staff members studied each report of 
influenza to determine if it met the case definition for 
severe-hospitalized influenza morbidity or mortality. 
Compatible cases were investigated further according 
to a standard protocol to collect demographic and 
disease information. 
 
Study Design and Approach 
In this prospective cohort study, data were collected 
upon receipt of laboratory-confirmation of influenza 
infection and admission to the hospital for greater 
than 24 hours. Patients were followed forward in time 
until either one of two outcomes occurred: discharge 
or death. A descriptive approach was utilized to 
depict the distribution of severe influenza-associated 
hospitalizations and deaths, and an analytical 
approach was utilized to identify associations 
between the various predictor variables of interest 
(i.e., age, gender, race, ethnicity, ICU status, 
mechanical ventilation status, underlying conditions, 
antiviral medications, and vaccination status) and 
death among the study population. 
 
Data Analysis 
The variables collected were operationalized and the 
following statistical methods and software were 
employed: Chi-Square and ANOVA statistical 
methods, Microsoft® Excel, and PASW, SPSS® 
software versions 18 and 19. Population-based 
hospitalization and mortality rates were calculated 
using the 2010 U.S. Census Bureau statistics for 
Clark County, Nevada (US Census Bureau, 2011).   
 
Human Subjects 
Institutional Review Board (IRB) approval was 
obtained for this research study from the UNLV IRB. 
The data collection process was completed by the 
SNHD in accordance with mandates set forth by the 
Nevada Administrative Code for the purposes of 
routine public health practice. The data were de-
identified of all personal patient identifiers, and 
permission was obtained from the SNHD to analyze 





One hundred and fifty-eight (N= 158) severe 
influenza-associated hospitalizations and deaths were 
reported to the SNHD for Clark County, Nevada 
during the study period. The first reported case 
occurred in the week ending October 2, 2010 (CDC 
week 39), and the last occurred in the week ending 
May 7, 2011 (week 17); the peak number of cases 
was reported in the week ending February 19, 2011 
(week 7) (Figure 1). Males accounted for 81 cases 
(51.3%); females accounted for 77 cases (48.7%). 
Race was obtained from the hospital medical records 
demographic face sheet, and subjects were 
categorized as follows: 9 Asian/Pacific Islander 
(5.7%), 27 black (17.1%), 2 Native American or 
Alaskan Native (1.3%), 81 white (51.3%), and 39 
other (24.7%). Approximately 71% of the study 
population was non-Hispanic (n= 112). Age of 
subjects ranged from newborn to over ninety years of 
age. 
 
Mortality and hospitalization rates 
During the study period, a total of 25 severe-
influenza associated deaths were reported to the 
SNHD. The overall severe influenza-associated 
mortality rate for Clark County based on the 2010 
census data (total population 1,951,269 residents in 
Clark County) was 1.28 per 100,000 (US Census 
Bureau, 2011). Severe influenza-associated 
hospitalizations and deaths were further categorized 
by age group, and by mortality and hospitalization 
rates by age group (Table 1). Females accounted for 
68% of deaths, even though the overall study 
population was normally distributed with regards to 
gender. A relative risk was calculated to determine if 
females were more likely to die than males, but these 
findings were not found to be statistically significant, 
RR= 2.235 (C.I. 0.972, 5.423), p= 0.059. 
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Figure 1.  Number of cases by ending date of week of hospital admission by strain type- Clark County, 2010-2011 
influenza season. 
 





All deaths by 




by age group † 
Hospitalization 




n= 25 (%) 1.28 n= 153 (%) 6.82 
< 5 
 
2 (8) 1.44 39 (25.5) 28.07 
5 – 49 
 
7 (28) 0.56 49 (32.0) 3.92 
50-59 
 
5 (20) 2.09 20 (13.1) 8.37 
60-69 
 
6 (24) 3.31 16 (10.5) 8.82 
70-79 
 
2 (8) 2.09 19 (12.4) 19.82 
≥ 80 
 
3 (12) 6.51 10 (6.5) 21.72 
Gender 
    Females 
 
17 (68) NA 74 (48.4) NA 
    Males 8 (32) NA 79 (51.6) NA 
*Includes both the deaths admitted to the hospital (n= 20) and those who were not (n= 5). 
†Includes deaths that were admitted to the hospital (n= 20). 
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To compare the 2010-2011 severe influenza 
morbidity and mortality rates to the national rates, the 
data were recalculated to reflect the same time period 
from October 1, 2010 through April 30, 2011 and to 
reflect the same age group categories utilized by the 
CDC (Table 2). Overall, the hospitalization rates in 
Clark County are significantly lower than those of the 
nation. 
 
Table 2.  Comparison of Clark County and U.S. national influenza-associated hospitalization rates from October 1, 
2010 through April 30, 2011. 
 
Age group 
Clark County, Nevada (n= 153)* United States† 
Hospitalization rate per 100,000 Hospitalization rate per 100,000 
0-4 years 
 
28.1 (n= 39) 43.8 
5- 17 years 
 
2.6 (n= 9) 8.5 
18-49 years 
 
4.4 (n= 40) 10.7 
50-64 years 
 
8.5 (n= 29) 21.7 
≥ 65 years 
 
16.3 (n= 36) 62.5 
*Includes deaths that were admitted to the hospital (n= 20). 
†FluSurv-NET surveillance data for the 2010-2011 influenza season (CDC, 2011a). 
 
According to the CDC (2011a), there were 311 
laboratory-confirmed deaths due to pneumonia and 
influenza in the U.S. during the 2010-2011 influenza 
season (October 3, 2010 through May 21, 2011). Of 
these deaths, 105 deaths were among children less 
than 18 years of age (CDC, 2011a). In Clark County, 
of the 25 reported deaths, there were 3 deaths under 
the age of 18 for this same time period. These rates 
were comparable to the national numbers, but due to 
the small sample size we are unable to make any 
further inferences regarding influenza-related 
pediatric deaths in Clark County. 
 
Influenza vaccination status 
Vaccination status was obtained on 132 of the 158 
subjects (83.5%). Individuals who received the 
influenza vaccine prior to 2010, during, or after their 
hospitalization were categorized as not having 
received the 2010-2011 influenza vaccine for the 
purposes of this study. Of the total study population 
(N= 158), 93 (58.9%) subjects were not vaccinated, 
39 subjects were (24.7%), and 26 subjects were 
classified as unknown (16.5%). Among the non-
vaccinated, 8 patients expired (8.6%), and among the 
vaccinated, 3 patients expired (7.7%); the remaining 
deaths (n= 14) had an unknown vaccination status. 
Chi-square analysis was run between vaccination 
status and death (excluding those that were classified 
as unknown), and vaccination status was not found to 
be significantly associated with death among 
hospitalized patients, χ² (1, n= 132) = 0.030, p= 
0.584. Fisher’s Exact Test p-value was reported due 
to the small sample size. Relative risk was calculated 
and also found to be non-significant, RR= 0.894 (C.I. 
0.192, 3.481) 
 
Influenza strain type 
The largest proportion of test results were reported as 
influenza rapid tests (n= 86, 54.4%), followed by 
real-time reverse transcriptase polymerase chain 
reaction (rRT-PCR) (n= 67, 42.4%), both rapid test 
and rRT-PCR (n= 4, 2.5%), and viral culture (n= 1, 
0.6%). The majority of testing occurred in the 
hospital laboratory setting (n= 91, 57.6%), and the 
remaining were performed either through commercial 
laboratories (n= 58, 36.7%), out-of-state laboratories 
(n= 8, 5.1%), or the Southern Nevada Public Health 
Laboratory (n= 1, 0.6%). Influenza A (no subtype) 
was the most commonly reported strain among severe 
influenza-associated hospitalizations and deaths (n= 
94, 59.4%), followed by influenza A (H1N1) (n= 36, 
22.8%), influenza B (n= 27, 17.1%), and influenza A 
(H3) (n= 1, 0.6%). 
 
Influenza strain was significantly associated with 
deaths, G= 16.2, p= 0.001.  Of the 36 cases diagnosed 
with influenza A (H1N1), 11 (30.6%) resulted in 
death. Patients diagnosed with influenza B (n= 27) 
demonstrated a similar proportion of deaths at 29.6% 
(n= 8). Influenza A (no subtype) was the most 
commonly diagnosed influenza strain (n= 94) in 
Clark County; however, it had the lowest proportion 
of deaths at 6.4% with 6 deaths occurring among 
those who tested laboratory positive. 
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The distribution of influenza strain by the ending date 
of the week of admission, or death in the case of 
those who expired at home (n= 5), is displayed in 
Figure 1. Results show the week ending on February 
19, 2011 (week 7) to be the peak of influenza-
associated hospitalizations and deaths in Clark 
County with 26 cases reported. According to the 
CDC summary of the 2010-2011 influenza season, 
national influenza activity peaked in early February 
as well (CDC, 2011a). 
 
Length of stay 
Length of hospital stay ranged from 1 to 59 days. The 
length of stay distribution for influenza-associated 
hospitalizations and deaths (n= 153) was non-normal 
(Shapiro-Wilks= 0.645, df 152, p< 0.0001), 
leptokurtic (kurtosis= 9.951), and skewed to the right 
(skewness= 2.897) because the majority of patients 
(70.4%) were admitted for ≤ 7 days and due to the 
influence of extreme outliers (Table 3). The mean 
length of stay was 7.70 days (95% C.I. 6.11, 9.30), 
SD= 9.943. The median and mode were calculated by 
influenza strain type and compared to the mean prior 
to log transformation (Table 3). 
 
Subjects who expired outside of the hospital setting 
(length of stay= 0 days) and the sole patient with 
laboratory-confirmed influenza A (H3N2) were 
excluded (n= 152) from further analyses. The non-
parametric equivalent of an ANOVA (Kruskal-
Wallis) was employed to investigate whether there 
was a statistically significant difference in the median 
length of stay based on influenza strain type using a 
rank test. These results were found to be non-
significant, p= 0.347. The length of stay data were 
log transformed to achieve a more normal 
distribution (skewness= 0.444, kurtosis= -0.390); 
afterward, all values in the data set fell within 3 
standard deviations of the mean (M= 1.500, SD= 
1.00). After transformation, an ANOVA was run 
between the log-transformed length of stay data and 
the influenza strain type. These results were also 
found to be non-significant, F= 0.893, p= 0.412, 
indicating that there was no statistically significant 
difference in the mean length of stay based on 
influenza strain type. 
 
An analysis of covariance (ANCOVA) was utilized 
to control for other factors that may influence the 
relationship between length of stay and influenza 
strain type. The following variables were evaluated: 
age, gender, race, ethnicity, ICU status, mechanical 
ventilation status, underlying conditions, antiviral 
medications, and vaccination status. The following 
factors were statistically significant in the final 
adjusted model: ICU status (p= 0.010), mechanical 
ventilation (p= 0.033), and underlying conditions (p= 
0.022). Further analyses of the underlying conditions 







Table 3.  Length of hospital stay by influenza strain type (mean, median, and mode prior to log transformation)- 




This research study describes the epidemiology of 
severe influenza-associated hospitalizations and 
deaths in Clark County, Nevada, for the 2010-2011 
influenza season. Results showed that the number of 
deaths identified in this study were lower in 
 
















Minimum 1 1 1 1 1 
Maximum 22 59 34 1 59 
Median 4 4 5.50 1 4 
Mode 2 2 2 1 2 
Mean 5.46 7.96 8.59 1 7.70 
Standard Deviation 4.836 11.273 8.560 NA 9.943 
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comparison to what is expected according to national 
numbers reported by a subset of states to the CDC. In 
comparison to males, a disproportionate number of 
females (68%) died as a result of severe influenza-
associated complications. Factors that may have 
contributed to this include small sample size and an 
undetermined combination of underlying conditions 
or co-morbidities among females in the study 
population. The greatest proportion of deaths 
occurred in the 5-49 age group (n= 7), and the lowest 
proportion of deaths occurred in the < 5 years and the 
70-79 years age groups (n= 2, for both). The small 
sample size may account for the fact that more deaths 
were not observed among the older age groups (≥ 65 
years), as would be expected according to national 
and historic trends (Thompson et al., 2010). 
 
The data showed a statistically significant difference 
among severe influenza-associated deaths by strain 
type. The proportion of deaths (n= 8) among patients 
diagnosed with influenza B was 29.6%, which was 
similar to the proportion of deaths (n= 11) among 
patients diagnosed with influenza A (H1N1) at 
30.6%. In comparison, the proportion of deaths 
among patients diagnosed with influenza A (no 
subtype) was much less at 6.4%. 
 
However, our study is limited by the laboratory 
testing ordered and performed on the study 
population. The majority of these tests were rapid 
antigen results; which are only able to differentiate 
between influenza A and influenza B viruses (CDC, 
2011b). Therefore, an unknown proportion of 
influenza A isolates (no subtype) could be any 
undetermined influenza A subtype. Not being able to 
differentiate between the influenza A subtypes is a 
significant limitation to our study because there are 
differences in virulence between the influenza A 
virus subtypes. Historically, this is supported by 
higher rates of hospitalizations and deaths during 
influenza seasons in which influenza (H3) viruses 
predominate (Thompson et al., 2010). Influenza rapid 
tests range in sensitivity from 50% to 70% and range 
in specificity from 90% to 95%; this translates to 
considerable variation in the positive and negative 
predictive values of the tests as the prevalence of 
disease fluctuates throughout the season (CDC, 
2011b). Because of these concerns, it is difficult to 
report the analysis of the influenza A (no subtype) 
data with external validity. 
 
Comparison of vaccination status with death among 
the study population demonstrated that there was no 
statistically significant association between 
vaccination status and death. These results should be 
interpreted cautiously due to the small sample size 
and the fact that vaccination status was only obtained 
on 11 of the 25 deaths, which renders these results 
inconclusive. The vaccination status classification 
“unknown” includes subjects who were unable to be 
confirmed through any of the methods described 
below. 
 
Vaccination status was the most difficult variable to 
collect because people have multiple sources 
throughout their community from which to obtain 
influenza vaccination. The SNHD registers patient 
vaccination information with the online statewide 
Nevada vaccination registry: WebIZ.  However, there 
is not one central source for immunization records, 
which made it difficult to find the vaccination status 
of people who received their influenza vaccination 
from sources other than the SNHD. Vaccination 
status was also limited by recall bias and death, 
further making it difficult to confirm. If the 
vaccination history was unknown, attempts were 
made to obtain vaccination records from multiple 
sources including hospital and provider patient 
records, and immunization registries. 
 
Lastly, the type of influenza vaccine (inactivated or 
live attenuated) administered was also not 
differentiated. It is difficult to ascertain if or how 
these omissions may have affected the analysis, but it 
may be a confounding factor in any associations 
between vaccination status and influenza-associated 
hospitalizations. In the future, more detailed data 
collection in regards to the vaccination status may 
resolve these limitations. 
 
There was no statistically significant difference in the 
mean length of stay based on the influenza strain 
type. This could be due to i) a relatively small sample 
size and unequal sample sizes once the study 
population was divided further by influenza strain 
types, and ii) lack of data reflecting the further 
characterization of the patients with laboratory-
confirmed influenza A (no subtype). As a result, we 
do not know what proportions of these patients were 
infected with influenza A (H3) or (H1) viruses, or 
possibly an unknown influenza A subtype. In 
addition, we do not have detailed data regarding 
underlying conditions with which to draw further 
conclusions (e.g., the presence of multiple underlying 
conditions, or what “other” conditions may include). 
There are many logistical factors that could extend 
the length of hospital stay (e.g., availability of 
outpatient beds), many of which were unable to be 
accounted for in this study. 
 
In the ANCOVA analysis, several factors were 
analyzed and only ICU status, placement on 
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mechanical ventilation, and underlying conditions 
were statistically significant.  The fact that admission 
to the ICU and placement on a mechanical ventilator 
extend length of stay was an expected finding, as 
both of these variables indicate a higher acuity of 
illness.  Further analyses of the underlying conditions 
were unable to be performed due to inadequate 
sample sizes. 
 
Multiple underlying conditions and co-morbidities 
were not analyzed in this study. If the patient did not 
have one of the conditions listed on the survey, a 
review of their medications was performed to 
determine if a medical condition existed that was not 
listed as an admitting diagnosis. Patients with 
multiple underlying conditions and co-morbidities 
were limited to the classification of just one. It is 
known that specific underlying conditions (e.g., 
asthma) and co-morbidities (e.g., COPD) can be 
exacerbated by influenza infection. Chronic health 
conditions can commonly occur in association with 
each other (e.g., diabetes and heart disease often 
occur in conjunction with one another), and this 
information would have been helpful in determining 
which combination of diseases contributed to severe 
influenza-associated deaths among our study 
population. Future surveillance projects should 
attempt to obtain this information in order to be able 
to further analyze these relationships. 
 
There are several limitations to consider when 
interpreting the findings from this secondary analysis 
of the 2010-2011 severe influenza-associated 
hospitalizations and deaths surveillance data 
collected by the SNHD. Foremost, it should be noted 
that the purpose of this project was for surveillance. 
The data collected are representative of routine public 
health practice and the data collection process is 
reflective of this; therefore, the analysis of these 
results is considered to be secondary and is subject to 
the limitations specific to secondary analyses. 
 
While our sample size for this study was small (N= 
158), the information gathered is still beneficial for 
future comparisons of severe influenza-associated 
hospitalizations and deaths surveillance data 
conducted in Clark County. It is expected that data 
obtained from the 2010-2011 severe influenza-
associated hospitalizations and deaths surveillance 
project will help guide subsequent projects and will 
provide an important database of information from 
which to compare future trends in the epidemiology 
of influenza specific to Clark County, Nevada. 
Surveillance systems are vital to public health efforts 
to protect the population; and influenza surveillance 
is especially vital because the virus is capable of 
changing its viral composition within a single flu 
season. 
 
Current national surveillance systems are only 
capable of capturing a limited picture of influenza 
activity each season. It is vital for smaller public 
health agencies, such as the SNHD, to conduct 
surveillance on severe-influenza hospitalizations and 
deaths. The SNHD is responsible for the public 
health of approximately 1.95 million people, roughly 
72% of Nevada’s population, as well as the estimated 
38 million people who visit Las Vegas as a popular 
tourism destination each year (LVCVA, 2011; US 
Census Bureau, 2011). To protect the population of 
any city, this requires surveillance of circulating 
strains, monitoring the population closely for unusual 
influenza activity, and monitoring severe influenza-
associated hospitalizations and deaths for potential 
changes in virulence. Changes in the influenza virus 
would most likely result in hospitalization or death, 
and because of this, projects such as this one are 
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